When all other treatments failed to cure the two infants of leukemia, doctors at London’s Great Ormond Street Hospital used genetically engineered immune cells from a donor to treat them. Reportedly the children are now in remission. Albeit a medical first, some researchers note that because the children received chemotherapy prior to the experimental treatment, "they failed to show the cell treatment actually cured the kids."
“The patient could be treated immediately, as opposed to taking cells from a patient and manufacturing them,” says Julianne Smith, vice president of CAR-T development for Cellectis, which specializes in supplying universal cells.
In the off-the-shelf approach, blood is collected from a donor and then turned into “hundreds” of doses that can then be stored frozen, says Smith. “We estimate the cost to manufacture a dose would be about $4,000,” she says. That’s compared to a cost of around $50,000 to alter a patient’s cells and return them.
|Men Who Purposely Contract AIDS to Improve Their Lives|
|"When it comes to growing intestines, the first inch is the hardest."|
|Why the swine flu virus is not a major threat|
|Ebola Reaches the United States|
|"It could become a powerful weapon in the battle against antimicrobial resistance."|
|“The direction of the cost of storage is less clear and depends on metals prices.”|
|“The era of climate wars has begun.”|
|Facebook, Twitter Users Could Face Insurance Hikes|
|The (Very Scary) People of Public Transit|
|How to Avoid Jury Duty|
|Naked Preacher Lady [NSFW]|
|“Bias, error, and misuse of Artificial Intelligence technologies.”|
|“We need to make algorithms transparent, regulated, and forgiving of the flawed creatures that converse with them.”|
|CaptchaTweet: Write Tweets in Captcha Form|
|Boardwalk Empire: Time Lapse Video|
|Fake Name Generator|